Immucor Rises 8% After Earnings (BLUD)

Immucor BLUD shares have risen more than 8% on Friday in early trade after the company reported better than expected earnings on Thursday after the closing bell. The company reported EPS of $0.30 versus analysts' consensus of $0.27. Year over year revenues were down 1.2%.